$MAJI (see link) FDA has granted Exousia AI Orphan Drug Designation for its shRNA for treatment of malignant glioma. Press Release and SEC filing imminent!!
accessdata.fda.gov/scripts/o…
147
$MULN is another production of disgraced blogger Chris LaCoursiere, the worldwide leader in losing fortunes. You've all been LaCurssssssssed
247
$GOLQ is another production of disgraced blogger Chris LaCoursiere, the worldwide leader in losing a fortune for the less fortunate.
319
#LIVGolf Tickets for today are now selling for $5 on Vividseats
$5 ea
GENERAL A.. • Row GA
1–7 tickets
Instant Delivery
321
$LGIQ is another production of failed blogger Chris LaCoursiere, the worldwide leader in failed promos. Research next time who is playing you.
233
$IMNM Stock went from $2.21 to $4.71 in 2 trading days before news today, SEC are you watching?
1
193
$LGIQ Fair value of this stock is around 5 cents so that's where I'm placing an order.
Your order below was placed:
Account: XXXX-6429
Order Number: 36578
Order type: Buy
Security: LGIQ
Term: GTC
Price type: Limit at $0.05
Quantity: 900000
1
$NFLX Variety reporting that NBC/Universal would love to buy Netflix
In recent weeks, Shell has told confidants that he’d love to buy Netflix, which has become more digestible thanks to its recent stock slide
variety.com/2022/film/news/c…
Let's not forget that $LGIQ is another production of @ChrisLaCoursie1 who is the worldwide leader in failed promotions. New 52 week low today, congrats to Chris aka LaCurse, Brent should have his head examined.
$LGIQ Brent Suen your promoter over at IHUB is spouting his typical lies, are you feeding him this false information? Don't let the SEC get involved in this charade.
1
LESSISMORE issues STRONG SELL rating on shares of LGIQ. Target price short term is $1.85.
LESSISMORE believes Company guidance implies a Net Loss for the Quarter of between $3 to $5 Million with comparable Net Losses for the foreseeable future.
© 2021 LESSISMORE
$LGIQ
1
$IMPL - Shame on Cowen!
9/3/2021
Cowen raised the price target on Impel $55.00 (from $35.00) while maintaining an Outperform rating.
9/7/2021
Impel NeuroPharma Announces Launch of Proposed Public Offering
Cowen is acting as joint bookrunning manager for the proposed offering.
2
$EXAS Exact Sciences granted EUA by US FDA
fda.gov/media/150558/downloa…
$VAPO
On 2/12/ 2021 Vapotherm's HVT 2.0 system was granted Emergency Use Authorization (EUA) by the FDA.
fda.gov/medical-devices/coro…
$QTRX
Quanterix receives FDA EUA for it's Covid-19 Antibody Test.
fda.gov/media/144761/downloa…
$SMMNY
Siemens Healthineers AG receives EUA from US FDA
fda.gov/media/144669/downloa…
